Treating Dystonia: What I have Learned So Far - Webinar with Dr. Alfonso Fasano


Topic: Treating Dystonia: What I have Learned So Far 

Presenter: Dr. Alfonso Fasano

When:  September 24, 2020 at 12:30 pm EST  

Summary: In an effort to continue to bring the dystonia community the education, tools, and resources we know you are looking for, we’re pleased to provide this webinar as part of the #mydystonia&I webinar series. This presentation will explore what Dr. Fasano has learned so far in his treatment of dystonia. We look forward to having you join us!

Watch Video

After registering, you will receive a confirmation email containing information about joining the webinar. We look forward to an informative, productive session. 

About Dr. Fasano and his research:

Dr. Alfonso Fasano graduated from the Catholic University of Rome, Italy, in 2002 and became a neurologist in 2007. After a 2-year fellowship at the University of Kiel, Germany, he completed a PhD in neuroscience at the Catholic University of Rome. In 2013 he joined the Movement Disorder Centre at Toronto Western Hospital, where he is the co-director of the surgical program for movement disorders. He is also an associate professor of medicine in the Division of Neurology at the University of Toronto and clinician investigator at the Krembil Research Institute. 

Dr. Fasano's main areas of interest are the treatment of movement disorders with advanced technology (infusion pumps and neuromodulation), pathophysiology and treatment of tremor and gait disorders. He authored more than 300 scientific papers and book chapters. Dr. Fasano is the co-editor of the section “Gaps and Controversies” of Movement Disorders Journal and editorial board member of Annals of Neurology, Movement Disorders Journal, Movement Disorders Clinical Practice and Parkinsonism and Related Disorders. He is also the principal investigator of several clinical trials.


The first 5 people that register and attend this webinar will win a 'Yoga for Movement Disorders' book (English), courtesy of Merz Therapeutics. 

Please note:

The answers to questions collected during registration are used for the purpose of customizing the webinar to address the various issues related to the topic. The purpose of this information collected is separate from the purpose of the personal details collected. The personally identifiable information of registrants is collected for correspondence purposes only and not shared with anyone outside of DMRF Canada.  

Also, the webinar will be recorded for playback purposes for those who cannot attend. 


Special Thanks to Our Sponsor:


Merz Logo